Trademark Overview
On Tuesday, April 8, 2025, a trademark application was filed for WALBAMPRA with the United States Patent and Trademark Office. The USPTO has given the WALBAMPRA trademark a serial number of 99127137. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 8, 2025. This trademark is owned by CivicaScript, LLC. The WALBAMPRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the treatment of neurological diseases or disorders; pharmaceutical products for the treatment of autoimmune diseases or disorders; pharmaceutical products for the treatment of multiple sclerosis; pharmaceutical products for the treatment of walking diseases and disorders